Spectrum Pharmaceuticals reported $366.5M in Market Capitalization this July of 2023, considering the latest stock price and the number of outstanding shares.



Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Actinium Pharmaceuticals USD 50M 6M Sep/2025
Agios Pharmaceuticals USD 1.59B 745M Dec/2025
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
Amgen USD 176.25B 24.32B Dec/2025
Arrowhead Research USD 9.02B 4.25B Dec/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
Bayer EUR 36.36B 9.13B Dec/2025
Biogen USD 25.82B 5.28B Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Coherus Biosciences USD 172M 19M Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Incyte USD 19.39B 2.83B Dec/2025
J&J USD 500.24B 67.44B Dec/2025
Karyopharm Therapeutics USD 652M 517M Apr/2026
Merck USD 261.26B 51.62B Dec/2025
Novartis USD 292.21B 26.55B Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Takeda JPY 7.64T 774.9B Dec/2025
Teva Pharmaceutical Industries USD 36.42B 14.06B Dec/2025
TG Therapeutics USD 4.73B 1B Dec/2025